Interestingly, Tsukamoto and colleagues [17] found that 40% of gastric cancer patients analyzed had a gain at 2q33 (the region in which the NRP-2 gene is located) by array comparative genomic hybridization (CGH) analysis, suggesting copy number aberration (CNA) of this region. The gene discussed is NRP2; the disease is gastric cancer.